Evidence for infectious agents in cardiovascular disease and atherosclerosis.

[1]  Y. Momiyama,et al.  Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. , 2001, Journal of the American College of Cardiology.

[2]  T. Mygind,et al.  Evaluation of real-time quantitative PCR for identification and quantification of Chlamydia pneumoniae by comparison with immunohistochemistry. , 2001, Journal of microbiological methods.

[3]  A. Kastrati,et al.  Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial , 2001, The Lancet.

[4]  G. Hansson,et al.  Chlamydia pneumoniae Infection Does Not Induce or Modify Atherosclerosis in Mice , 2001, Circulation.

[5]  H. Sørensen,et al.  Risk of hospitalization for cardiovascular disease after use of macrolides and penicillins: a comparative prospective cohort study. , 2001, The Journal of infectious diseases.

[6]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[7]  A. Shor.  A pathologist's view of organisms and human atherosclerosis. , 2001, The Journal of infectious diseases.

[8]  M. Burnett,et al.  Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. , 2001, Atherosclerosis.

[9]  B. Coombes,et al.  Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role? , 2001, FEMS microbiology letters.

[10]  M. Leinonen,et al.  Chlamydia pneumoniae Does Not Increase Atherosclerosis in the Aortic Root of Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[11]  P. Roholl,et al.  Distribution of Chlamydia pneumoniae in the Human Arterial System and Its Relation to the Local Amount of Atherosclerosis Within the Individual , 2001, Circulation.

[12]  R. Zinkernagel,et al.  Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses1 , 2001, The Journal of Immunology.

[13]  R. Leiguarda,et al.  Detection of Helicobacter pylori in Human Carotid Atherosclerotic Plaques , 2001, Stroke.

[14]  G. Stanek,et al.  Multicenter Comparison Trial of DNA Extraction Methods and PCR Assays for Detection of Chlamydia pneumoniae in Endarterectomy Specimens , 2001, Journal of Clinical Microbiology.

[15]  C. Lowenstein,et al.  Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. , 2001, The Journal of infectious diseases.

[16]  C. Ballantyne,et al.  A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy , 2000, Journal of Molecular Medicine.

[17]  M. Sarvas,et al.  Picornavirus proteins share antigenic determinants with heat shock proteins 60/65 , 2000 .

[18]  M. Trevisan,et al.  Identification of periodontal pathogens in atheromatous plaques. , 2000, Journal of periodontology.

[19]  P. Vallance,et al.  Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. , 2000, Circulation.

[20]  J. Danesh,et al.  Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. , 2000, BMJ : British Medical Journal.

[21]  M. Leinonen.  Chlamydia pneumoniae and other risk factors for atherosclerosis. , 2000, The Journal of infectious diseases.

[22]  Indrawati,et al.  Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. , 2000, The Journal of infectious diseases.

[23]  P. Saikku,et al.  Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[24]  Y. Shoenfeld,et al.  Autoimmunity in atherosclerosis , 2000, Clinical reviews in allergy & immunology.

[25]  M. Leinonen,et al.  Infections, inflammation, and the risk of coronary heart disease. , 2000, Circulation.

[26]  A. Quyyumi,et al.  Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. , 2000, The American journal of cardiology.

[27]  Maija Leinonen, Pekka Saikku.  Infections and Atherosclerosis , 2000, Scandinavian cardiovascular journal : SCJ.

[28]  N. Mackman.  Lipopolysacharide induction of gene expression in human monocytic cells , 2000, Immunologic research.

[29]  I. Fong,et al.  De Novo Induction of Atherosclerosis byChlamydia pneumoniae in a Rabbit Model , 1999, Infection and Immunity.

[30]  J. Fabricant,et al.  Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens. , 1999, American heart journal.

[31]  C. Bruggeman,et al.  Cytomegalovirus and atherogenesis. , 1999, Antiviral research.

[32]  Jianhui Zhu,et al.  Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.

[33]  P. Saikku,et al.  Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia , 1999, The Lancet.

[34]  M. Rosenfeld,et al.  Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. , 1999, The Journal of infectious diseases.

[35]  G. Schmitz,et al.  C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. , 1999, Circulation.

[36]  V. Tsang,et al.  Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. , 1999, Circulation.

[37]  R. Perondi,et al.  Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. , 1999, Circulation.

[38]  B. Psaty,et al.  Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline. , 1999, Emerging infectious diseases.

[39]  J. Danesh,et al.  Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease , 1999, Heart.

[40]  G. Zhong,et al.  The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. , 1999, The Journal of clinical investigation.

[41]  J. Penninger,et al.  Chlamydia infections and heart disease linked through antigenic mimicry. , 1999, Science.

[42]  P. Libby,et al.  Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. , 1999, The Journal of clinical investigation.

[43]  H Jick,et al.  Antibiotics and risk of subsequent first-time acute myocardial infarction. , 1999, JAMA.

[44]  I. Paakkari,et al.  Infection-associated intimal thickening in the coronary arteries of children. , 1999, Atherosclerosis.

[45]  M. Leinonen,et al.  Association of Helicobacter pylori infection with elevated serum lipids. , 1999, Atherosclerosis.

[46]  P. Jousilahti,et al.  Enterovirus infections as a possible risk factor for myocardial infarction. , 1998, Circulation.

[47]  B. Thomas,et al.  Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies. , 1998, Journal of clinical pathology.

[48]  S. Söderberg,et al.  High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. , 1998, The Journal of infectious diseases.

[49]  H. Jick,et al.  Acute respiratory-tract infections and risk of first-time acute myocardial infarction , 1998, The Lancet.

[50]  J. Kaprio,et al.  Immune responses to Chlamydia pneumoniae in twins in relation to gender and smoking. , 1998, Journal of medical microbiology.

[51]  Koskenvuo,et al.  Chlamydia pneumoniae‐Specific Cell‐Mediated and Humoral Immunity in Healthy People , 1998, Scandinavian journal of immunology.

[52]  A. C. Nicholson,et al.  Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[53]  M. Nieminen,et al.  Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  J. Carlquist,et al.  Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. , 1998, Circulation.

[55]  P. Libby,et al.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. , 1997, Circulation.

[56]  M. Leinonen,et al.  Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[57]  M. Leinonen,et al.  Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits , 1997, Infection and immunity.

[58]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[59]  E. Gurfinkel,et al.  Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study , 1997, The Lancet.

[60]  A. Camm,et al.  Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial Infarction , 1997 .

[61]  E. Vartiainen,et al.  Symptoms of chronic bronchitis and the risk of coronary disease , 1996, The Lancet.

[62]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[63]  G. Dahlén,et al.  Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. , 1995, Atherosclerosis.

[64]  D. Strachan,et al.  Fibrinogen: a link between chronic infection and coronary heart disease , 1994, The Lancet.

[65]  D. Strachan,et al.  Relation of Helicobacter pylori infection and coronary heart disease. , 1994, British heart journal.

[66]  P. Saikku.  Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. , 1993, European heart journal.

[67]  A. Folsom,et al.  Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1993, The American journal of medicine.

[68]  M. Puolakkainen,et al.  Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques , 1993, Journal of clinical microbiology.

[69]  D. Patton,et al.  Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. , 1992, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[70]  K. Feingold,et al.  Tumor Necrosis Factor, Interleukin, and Interferon Induced Changes in Lipid Metabolism as Part of Host Defense , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[71]  H. Caldwell,et al.  Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein , 1989, The Journal of experimental medicine.

[72]  K. Mattila.  Viral and bacterial infections in patients with acute myocardial infarction , 1989, Journal of internal medicine.

[73]  M. Nieminen,et al.  Association between dental health and acute myocardial infarction. , 1989, BMJ.

[74]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[75]  A. Robertson,et al.  Herpesviridae in the coronary arteries and aorta of young trauma victims. , 1988, The American journal of pathology.

[76]  D. Spodick,et al.  Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. , 1984, The American journal of cardiology.

[77]  J. McDougall,et al.  Viruses in the etiology of atherosclerosis. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Debakey,et al.  CYTOMEGALOVIRUS ANTIGEN WITHIN HUMAN ARTERIAL SMOOTH MUSCLE CELLS , 1983, The Lancet.

[79]  D. Mckie.  Editorial: Where the axe is falling. , 1974, Lancet.